cx 4945 Search Results


cx4945  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology cx4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx4945, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pm27746184-55-3-4?v=Santa+Cruz+Biotechnology
Average 90 stars, based on 1 article reviews
cx4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx 4945  (Biosynth Carbosynth)
93
Biosynth Carbosynth cx 4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/bio_rxiv__2024__03__20__585970-172-10-11?v=Biosynth+Carbosynth
Average 93 stars, based on 1 article reviews
cx 4945 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
cx-4945  (Cylene Pharmaceuticals)
90
Cylene Pharmaceuticals cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by Cylene Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc05409130-232-0-1?v=Cylene+Pharmaceuticals
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945 (5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid  (MedKoo Inc)
90
MedKoo Inc cx-4945 (5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945 (5 (3 Chlorophenylamino)benzo[C][2,6]Naphthyridine 8 Carboxylic Acid, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pm35755813-57-31-52?v=MedKoo+Inc
Average 90 stars, based on 1 article reviews
cx-4945 (5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945  (SYNkinase)
90
SYNkinase cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by SYNkinase, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc04254219-91-2-3?v=SYNkinase
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ck2-specific inhibitor cx-4945  (Advanced ChemBlocks Inc)
90
Advanced ChemBlocks Inc ck2-specific inhibitor cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Ck2 Specific Inhibitor Cx 4945, supplied by Advanced ChemBlocks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc09286742-366-5-9?v=Advanced+ChemBlocks+Inc
Average 90 stars, based on 1 article reviews
ck2-specific inhibitor cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945  (Adooq Bioscience LLC)
90
Adooq Bioscience LLC cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pm27040916-238-18-19?v=Adooq+Bioscience+LLC
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945  (Senhwa Biosciences)
90
Senhwa Biosciences cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by Senhwa Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pm30396934-53-3-4?v=Senhwa+Biosciences
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945  (CEM Corporation)
90
CEM Corporation cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc08914513-138-42-9?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945 apexbio a8330  (ApexBio)
90
ApexBio cx-4945 apexbio a8330
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945 Apexbio A8330, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc05740873-438-42-43?v=ApexBio
Average 90 stars, based on 1 article reviews
cx-4945 apexbio a8330 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
silmitasertib cx-4945  (Merck KGaA)
90
Merck KGaA silmitasertib cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Silmitasertib Cx 4945, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pmc09028559-92-0-5?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
silmitasertib cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cx-4945  (AbMole Bioscience)
90
AbMole Bioscience cx-4945
Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, <t>CX4945</t> (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.
Cx 4945, supplied by AbMole Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cx+4945/pm29242563-205-0-4?v=AbMole+Bioscience
Average 90 stars, based on 1 article reviews
cx-4945 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, CX4945 (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.

Journal: The American journal of pathology

Article Title: CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients.

doi: 10.1016/j.ajpath.2016.08.007

Figure Lengend Snippet: Figure 2 Inhibition of CSNK2A1 decreased the proliferation and invasiveness of breast cancer cells. A and B: Treatment with the CSNK2 inhibitors, CX4945 (A) and emodin (B), significantly inhibited the growth of both MCF7 and T47D cells in a dose- and time-dependent manner. C: The knockdown of CSNK2A1 inhibited the proliferation of both MCF7 and T47D cells as indicated by MTT and colony-forming assays. D: The sub-G1 and G0/G1 population increased with the knockdown of CSNK2A1 in flow cytometric cell cycle analysis. E and F: The knockdown of CSNK2A1 significantly reduced cell migration (E) and invasion (F) in both MCF7 and T47D cell lines. *P < 0.05, **P < 0.01, and ***P < 0.001. CSNK2A1, casein kinase 2 a1.

Article Snippet: Two CSNK2 inhibitors, CX4945 (Santa Cruz Biotechnology, Santa Cruz, CA) and emodin (Sigma-Aldrich, St. Louis, MO), were used.

Techniques: Inhibition, Knockdown, Cell Cycle Assay, Migration